![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
DAPAGLIFLOZIN AND METOPROLOL BOTH COMBINATION DRUGS USED IN TREATMENT OF HEART FAILURE
Nidhi Tadvi*, Krishna Kalsara and Dr. Umesh Upadhyay
ABSTRACT
Based on the results from dedicated cardiovascular outcome trials (CVOTs), current guidelines suggest the use of SGLT-2 inhibitors for patients with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or heart failure. Keywords: Heart failure, dapagliflozin, metoprolol. [Download Article] [Download Certifiate] |